Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. ACETABULAR CUP; HIP COMPONENT
FDA Home
Medical Devices
Databases
-
510(k)
|
DeNovo
|
Registration & Listing
|
Adverse Events
|
Recalls
|
PMA
|
HDE
|
Classification
|
Standards
CFR Title 21
|
Radiation-Emitting Products
|
X-Ray Assembler
|
Medsun Reports
|
CLIA
|
TPLC
MICROPORT ORTHOPEDICS INC. ACETABULAR CUP; HIP COMPONENT
Back to Search Results
Model Number
PHA06214
Medical Device Problem Code
Loss of Osseointegration (2408)
Health Effect - Clinical Code
No Known Impact Or Consequence To Patient (2692)
Type of Reportable Event
Serious Injury
Event or Problem Description
Allegedly, patient was revised due to septic loosening.
Additional Manufacturer Narrative
Correct awareness date (b)(6) 2019.
Search Alerts/Recalls
New Search
|
Submit an Adverse Event Report
Brand Name
ACETABULAR CUP
Common Device Name
HIP COMPONENT
Manufacturer
(Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key
9717859
Report Number
3010536692-2020-00125
Device Sequence Number
16234837
Product Code
HWT
UDI-Device Identifier
M684PHA062141
UDI-Public
M684PHA062141
Combination Product (Y/N)
N
Initial Reporter Country
IT
Number of Events Summarized
1
Summary Report (Y/N)
N
Device Implanted Year
2007
Device Explanted Year
2016
Reporter Type
Manufacturer
Report Source
other
Initial Reporter Occupation
Other Health Care Professional
Type of Report
Initial,Followup
Report Date
(Section B)
02/17/2020
1
Device was Involved in the Event
1
Patient was Involved in the Event
Is this an Adverse Event Report?
Yes
Is this a Product Problem Report?
No
Operator of Device
Other
Device Model Number
PHA06214
Device Catalogue Number
PHA06214
Device Lot Number
X01383963
Was Device Available for Evaluation?
No
Was the Report Sent to FDA?
No
Distributor Facility Aware Date
07/02/2019
Type of Report(Section G)
Thirty-Day
Initial Date Received by Manufacturer
07/02/2020
Supplement Date Received by Manufacturer
07/02/2020
Initial Report FDA Received Date
02/17/2020
Supplement Report FDA Received Date
02/18/2020
Patient Sequence Number
1
Outcome Attributed to Adverse Event
Required Intervention;
Patient Age
67 YR
-
-